Literature DB >> 1273617

The syndrome of retroperitoneal hemorrhage and lumbar plexus neuropathy during anticoagulant therapy.

W S Chiu.   

Abstract

A syndrome of retroperitoneal hemorrhage during anticoagulant therapy associated with nerve involvement in femoral nerve or lumbar plexus is described. Twenty-one cases were collected from the English-language literature, and five new cases were added for review and analysis. In these 26 cases spontaneous hemorrhage occurred under iliopsoas fascia in the retroperitoneal space. The clinical picture, involved nerves, laboratory findings of coagulation studies, anemia, and the outcome of these cases are summarized and discussed. Retroperitoneal space may contain a large quantity of internal hemorrhage. Irreversible damage of lumbar plexus or femoral nerve may result from entrapment of nerves in the hematoma. Laboratory coagulation studies may guide effective administration of anticoagulant therapy and minimize hemorrhagic complication, but they will not eliminate the risk of hemorrhage completely.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1273617     DOI: 10.1097/00007611-197605000-00034

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Parotid gland hemorrhage as a complication of coumarin compound ingestion.

Authors:  D Zikk; E Shanon; U Seligsohn; M Z Himelfarb
Journal:  Arch Otorhinolaryngol       Date:  1985

2.  Local and systemic consequences of large retroperitoneal clot burdens.

Authors:  Gabriel Loor; Hisham Bassiouny; Carl Valentin; Michael Y Shao; Brian Funaki; Tina Desai
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

3.  Simultaneous femoral nerve palsy due to hemorrhage in both iliac muscles.

Authors:  F Barontini; M Macucci
Journal:  Ital J Neurol Sci       Date:  1986-08

4.  Lumbosacral plexopathy due to pelvic hematoma after extracorporeal membrane oxygenation: A case report.

Authors:  Anson W Wilks; Muhammad T Al-Lozi
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.